Cover Image

Design, Synthesis, and Evaluation of Novel Cryptotanshinone Derivatives for Activity against Triple-Negative Breast Cancer

Saved in:

Bibliographic Details
Main Authors:	Siyu Liu (Author), Panpan Zhang (Author), Qingyan Sun (Author)
Format:	Book
Published:	Georg Thieme Verlag KG, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines
by: Paola Maria Bonaccorsi, et al.
Published: (2019)

Design, synthesis and biological evaluation of novel tetrahydrothieno [2,3-c]pyridine substitued benzoyl thiourea derivatives as PAK1 inhibitors in triple negative breast cancer
by: Dahong Yao, et al.
Published: (2020)

Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer
by: Hanzhi Liang, et al.
Published: (2022)

Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer
by: Tong Gao, et al.
Published: (2023)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017)

Immunotherapy for Triple-Negative Breast Cancer
by: Yifeng Cao, et al.
Published: (2021)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020)

One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells
by: Wagdy M. Eldehna, et al.
Published: (2018)

Potential action of cardamom (Elettaria cardamomum) against triple-negative breast cancer
by: Akash Samanta, et al.
Published: (2023)

Macrophage Delivered HSV1716 Is Active against Triple Negative Breast Cancer
by: Amy Kwan, et al.
Published: (2022)

Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer
by: Fan T, et al.
Published: (2024)

Brain Metastasis in Triple-Negative Breast Cancer
by: Eduarda Bustamante, et al.
Published: (2024)

Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021)

Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
by: Yubao Zhang, et al.
Published: (2021)

Anticancer potential of cryptotanshinone on breast cancer treatment; A narrative review
by: Davood Dalil, et al.
Published: (2022)

Target Analysis and Mechanism of Podophyllotoxin in the Treatment of Triple-Negative Breast Cancer
by: Wenfeng Zhang, et al.
Published: (2020)

Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
by: Aiswarya Chaudhuri, et al.
Published: (2022)

Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer
by: Mahak Fatima, et al.
Published: (2022)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014)

Neighborhood Social Determinants of Triple Negative Breast Cancer
by: Fokhrul Hossain, et al.
Published: (2019)

Role of flavonoids in inhibiting triple-negative breast cancer
by: Shuai Wang, et al.
Published: (2024)

Oncolytic viruses for triple negative breast cancer and beyond
by: Shengye Jin, et al.
Published: (2021)

HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
by: Cristina Maccallini, et al.
Published: (2022)

The Roles of DNA Demethylases in Triple-Negative Breast Cancer
by: Shoghag Panjarian, et al.
Published: (2021)

Triple-Negative Lobular Breast Cancer Causing Hydronephrosis
by: Michael Chahin DO, et al.
Published: (2020)

Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020)

Dipeptide PA3264 derived from rare and endangered Squama Manis is a novel bioactive peptide for the treatment of triple-negative breast cancer
by: Xiaorong Hou, et al.
Published: (2024)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021)

Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer
by: Huang Wen, et al.
Published: (2023)

Naples Prognostic Score: A Novel Predictor of Survival in Patients with Triple-Negative Breast Cancer
by: Qiu Y, et al.
Published: (2024)

Cryptotanshinone Is a Intervention for ER-Positive Breast Cancer: An Integrated Approach to the Study of Natural Product Intervention Mechanisms
by: Huayao Li, et al.
Published: (2021)

Prognostic impact of PTK6 expression in triple negative breast cancer
by: Yuexia Chen, et al.
Published: (2023)

LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer
by: Jiahao Qiu, et al.
Published: (2022)

Update on triple-negative breast cancer: prognosis and management strategies
by: Brouckaert O, et al.
Published: (2012)

Editorial: Targeting triple negative breast cancer by natural compounds
by: Shashank Kumar, et al.
Published: (2023)

RNA nanoparticles for targeted therapies of triple-negative breast cancers
by: Leyla Danai, et al.
Published: (2023)

The role of taxanes in triple-negative breast cancer: literature review
by: Mustacchi G, et al.
Published: (2015)

Current and emerging treatment options in triple-negative breast cancer
by: Omer Dizdar, et al.
Published: (2011)

Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer
by: Won-Ji Ryu, et al.
Published: (2021)